Structural and functional basis of VLDLR usage by Eastern equine encephalitis virus.
Adams LJ, Raju S, Ma H, Gilliland T Jr, Reed DS, Klimstra WB, Fremont DH, Diamond MS.
Cell. 2024 Jan 18;187(2):360-374.e19. doi: 10.1016/j.cell.2023.11.031. Epub 2024 Jan 3.
PMID:38176410
[Clinical features of autoimmune encephalitis secondary to epidemic encephalitis B in 5 children].
Song LF, Wang L, Tang ZH, Xian YX, Liu K, Ma YN.
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):302-307. doi: 10.7499/j.issn.1008-8830.2211082.
PMID:36946167
Vaccine introduction in the Democratic People's Republic of Korea.
Marks F, Nyambat B, Xu ZY, von Kalckreuth V, Kilgore PE, Seo HJ, Du Y, Park SE, Im J, Konings F, Meyer CG, Wierzba TF, Clemens JD.
Vaccine. 2015 May 11;33(20):2297-300. doi: 10.1016/j.vaccine.2015.03.005. Epub 2015 Mar 10.
PMID:25769209
Epidemic type B encephalitis: its clinical manifestation and treatment with traditional Chinese medicine.
CHOU HC.
Chin Med J. 1960 Jun;80:548-53.
PMID:13810020
Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus.
Etna MP, Signorazzi A, Ricci D, Severa M, Rizzo F, Giacomini E, Gaggioli A, Bekeredjian-Ding I, Huckriede A, Coccia EM.